摘要
认知障碍(CI)病因是多因素的。一些研究表明,炎症,氧化和抗氧化状态和体力活动与认知障碍相关。然而,关于这一问题的证据仍然是有争议的。本研究的目的是验证热量消耗的物理活性,氧化,抗氧化能力和炎症生物标志物与认知障碍在老年人中的关联。在Porto Alegre, Rio Grande do Sul, Brazil,从家庭健康策略的患者我们进行了一项424老年人的代表性研究(224认知功能正常,200认知障碍)。调查的变量是人口社会学、生化、炎症(hs-CRP, IL-6)、氧化(TBARS,AOPP),抗氧化能力(FRAP)的生物标志物,能量消耗,和认知功能。所使用的仪器是the Minnesota Leisure Time Physical Activity Questionnaire + Compendium of Physical Activities,对人体活动的能源成本的分类(体力活动评价与METs能量消耗测量),和一连串的精神工具(认知能力评估)。我们发现统计上只有涉及到高密度脂蛋白胆固醇与年龄(高平均年龄在认知障碍组;P<0.05)显着差异。我们没有观察到的生化、炎症、氧化和FRAP的生物标志物或热量消耗的差异。非条件多元回归分析显示,高密度脂蛋白胆固醇(OR=1.02 [IC=95%; 1.01-1.04]; P=0.011),年龄(OR=1.05 [IC=95%; 1.02–1.08]; P=0.004)与认知障碍的独立因素。我们的研究结果表明,生化(除高密度脂蛋白胆固醇)、炎症、氧化和生物标志物研究和FRAP热量支出不与认知障碍中老年人辅助初级保健相关。
关键词: 老化,抗氧化,热量消耗,认知障碍,炎症,氧化。
Current Alzheimer Research
Title:Inflammation, Oxidation, Caloric Expenditure and Cognitive Impairment in Brazilian Elderly Assisted at Primary Care
Volume: 13 Issue: 9
Author(s): Guilherme M. Nogueira, Carla H.A. Schwanke, Vera E. Closs, Bruna Luz, Rafael N. Moresco, Etiane Tatsch, Guilherme V. Bochi and Joao F.D. de Moraes, Camila B. Jacondino, Irenio Gomes, Maria G.V. Gottlieb
Affiliation:
关键词: 老化,抗氧化,热量消耗,认知障碍,炎症,氧化。
摘要: Cognitive impairment (CI) has a multifactorial etiology. Some studies have suggested that inflammatory, oxidative and antioxidant status and physical activity are associated with CI. However, the evidence on this subject is still controversial. The goal of this study was to verify the association of caloric expenditure by physical activity, oxidative, antioxidant power and inflammatory biomarkers with CI in older adults. We performed a cross-sectional study of 424 elderly (224 with normal cognitive function and 200 with CI) patients from the Family Health Strategy in Porto Alegre, Rio Grande do Sul, Brazil. The variables investigated were sociodemographic, biochemical, inflammatory (hs-CRP, IL-6), oxidative (TBARS, AOPP), antioxidant power (FRAP) biomarkers, energy expenditure, and cognitive function. The instruments used were the Minnesota Leisure Time Physical Activity Questionnaire + Compendium of Physical Activities, classification of energy costs of human physical activities (for physical activity evaluation and measurement of energy expenditure in METs), and a battery of neuropsychiatric instruments (for cognitive ability assessment). We found statistically significant differences only with respect to HDL-c and age (higher averages in the CI group; P<0.05). We observed no differences between the groups with respect to biochemical, inflammatory, oxidative and FRAP biomarkers or caloric expenditure. Logistic regression showed that HDL-c (OR=1.02 [IC=95%; 1.01-1.04]; P=0.011), and age (OR=1.05 [IC=95%; 1.02–1.08]; P=0.004) are independent factors associated with CI. Our results suggest that the biochemical (except HDL-c), inflammatory, oxidative, and FRAP biomarkers investigated and caloric expenditure are not associated with CI in the elderly assisted at primary care.
Export Options
About this article
Cite this article as:
Guilherme M. Nogueira, Carla H.A. Schwanke, Vera E. Closs, Bruna Luz, Rafael N. Moresco, Etiane Tatsch, Guilherme V. Bochi and Joao F.D. de Moraes, Camila B. Jacondino, Irenio Gomes, Maria G.V. Gottlieb , Inflammation, Oxidation, Caloric Expenditure and Cognitive Impairment in Brazilian Elderly Assisted at Primary Care, Current Alzheimer Research 2016; 13 (9) . https://dx.doi.org/10.2174/1567205013666160401114415
DOI https://dx.doi.org/10.2174/1567205013666160401114415 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sepsis-induced Cardiomyopathy
Current Cardiology Reviews The Hepatic Lipidome: A Gateway to Understanding the Pathogenes is of Alcohol-Induced Fatty Liver
Current Molecular Pharmacology The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design Natural Triterpenoids and their Derivatives with Pharmacological Activity Against Neurodegenerative Disorders
Mini-Reviews in Organic Chemistry QT Alterations in Psychopharmacology: Proven Candidates and Suspects
Current Drug Safety CYP-Mediated Clozapine Interactions: How Predictable Are They?
Current Drug Metabolism Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Preface
Current Cardiology Reviews Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?
Current Stem Cell Research & Therapy Cardiovascular Drugs Inducing QT Prolongation: Facts and Evidence
Current Drug Safety Cardiomyopathy of Pregnancy
Current Women`s Health Reviews Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations
Current Pharmaceutical Biotechnology A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery
Current Vascular Pharmacology Syncope: Review of Monitoring Modalities
Current Cardiology Reviews Matrix Metalloproteinase Knockout Studies and the Potential Use of Matrix Metalloproteinase Inhibitors in the Rheumatic Diseases
Current Drug Targets - Inflammation & Allergy New Frontiers in Regenerative Medicine in Cardiology: The Potential of Wharton’s Jelly Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Ultrasound Techniques for Drug Delivery in Cardiovascular Medicine
Current Drug Discovery Technologies Editorial [Hot Topic: Matrix Metalloproteinases in Cardiovascular Disease (Guest Editors: N. Papageorgiou & D. Tousoulis)]
Current Topics in Medicinal Chemistry MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy
Current Gene Therapy